India administered more than 10 million vaccine doses in the past 24 hours, a national record that Prime Minister Narendra Modi called a “momentous feat” for the country ahead of fears of another surge in infections. India has administered more than 622 million vaccine doses in total, giving at least one dose to more than half of its 944 million adults.This has been achieved through 67,19,042 sessions.
Category:
Pandemic
Latest
Covid-19 not developed as biological weapon: US intelligence community
The Director of National Intelligence in a report, prepared at the direction of the president, on Friday said SARS-CoV-2 probably emerged and infected humans through an initial small-scale exposure that occurred no later than November 2019 with the first known cluster of COVID-19 cases arising in Wuhan, China in December 2019.
However, there was no unanimity among the intelligence community (IC) on the origins of the coronavirus.
Covid-19’s Delta variant doubles hospitalisation risk, finds study
“Our analysis highlights that in the absence of vaccination, any delta outbreaks will impose a greater burden on healthcare than an alpha epidemic,” said Anne Presanis, one of the study’s lead authors and a senior statistician at Cambridge. “Getting fully vaccinated is crucial for reducing an individual’s risk of symptomatic infection with delta.”
Britain gets ready for roll-out of Pfizer’s COVID-19 vaccine this week
Some of the most famous figures in British life stepped forward to say that they would receive the vaccine to encourage the public to follow suit. That could include Queen Elizabeth II and her husband Prince Philip, who are likely to receive the vaccine within weeks, according to MailOnline reports on Sunday.
India’s Serum Institute seeks emergency use nod for AstraZeneca’s COVID-19 vaccine
The move comes close on the heels of Pfizer Inc applying for a similar authorization of its coronavirus vaccine in India on Saturday.
Pfizer seeks emergency approval for COVID-19 vaccine in India, media say
The U.S. company, whose vaccine was recently approved by the British government, has written to the Drugs Controller General of India (DCGI), CNN-News18 reported citing a government source.Officials at the DCGI and the health ministry did not respond to requests for comment. A government official, however, told Reuters that no application had been received as of Saturday night.
COVID-19 could push number of people living in extreme poverty to over 1 billion by 2030: UN
“Severe long-term effects of the COVID-19 pandemic could push an additional 207 million people into extreme poverty on top of the current pandemic trajectory, bringing the total to over 1 billion by 2030,” noted the study.
The ‘Baseline COVID’ scenario, based on current mortality rates and the most recent growth projections by the International Monetary Fund (IMF), would result in 44 million more people living in extreme poverty by 2030 compared to the development trajectory the world was on before the pandemic.
Economy to reach pre-Covid-19-levels by end of FY2022: Niti Aayog
India’s economy recovered faster than expected in the September quarter as a pick-up in manufacturing helped GDP clock a lower contraction of 7.5 per cent and held out hopes for further improvement on better consumer demand.
Almost all COVID-19 patients develop antibodies: WHO
“What we understand is 90 to 100 per cent of people who are infected with the virus do develop an antibody response, whether you have mild infection or asymptomatic infection all the way to severe infection. And we’re still learning how long that antibody response lasts, how strong it is, how it relates to immunity from another infection, and how long that lasts,” Van Kerkhove, an expert on epidemiology, said at a virtual press briefing.
Moscow rolls out Sputnik V COVID-19 vaccine to most exposed groups
Scientists have raised concerns about the speed at which Russia has worked, giving the regulatory go-ahead for its vaccines and launching mass vaccinations before full trials to test its safety and efficacy had been completed.
Now that vaccines are coming, what about poor countries?
By Andreas Kluth It’s now just a matter of weeks before shoulders are bared, syringes primed and vaccines injected. If last year was the one that gave Covid-19 its name and 2020 was defined by masks, gowns and swabs, 2021 will be the year of the...
Bharat Biotech says COVAXIN efficacious, safe, as Anil Vij tests positive for Covid-19
The drug firm said its vaccine Covaxin is based on two dose schedule and its efficacy is determined 14 days post the second dosage. “COVAXIN clinical trials are based on a 2-dose schedule, given 28 days apart. The vaccine efficacy will be determined 14 days post the second dose,” Bharat Biotech said in a statement.
COVID-19: 36,652 new cases take India’s virus tally to 96,08,211
The COVID-19 case fatality rate was recorded at 1.45 per cent
There are 4,09,689 active cases of coronavirus infection in the country which comprises 4.26 per cent of the total caseload, the data stated